摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-Br-NAD+ | 52977-37-4

中文名称
——
中文别名
——
英文名称
8-Br-NAD+
英文别名
[[(2R,3S,4R,5R)-5-(6-amino-8-bromopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate
8-Br-NAD+化学式
CAS
52977-37-4
化学式
C21H26BrN7O14P2
mdl
——
分子量
742.327
InChiKey
ISNAGOUAZGHQIY-NAJQWHGHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -5
  • 重原子数:
    45
  • 可旋转键数:
    11
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    321
  • 氢给体数:
    7
  • 氢受体数:
    18

SDS

SDS:f16057aa264c1d867fcf28efdea3110d
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Kinetics and docking studies on the effect of chemical modification of NADH for redox reactions with dehydrogenases
    摘要:
    Cofactor analogs promise important applications in biosynthesis. The effect of chemical modification on the reactivity of NADH for redox reactions catalyzed by dehydrogenases was examined in this work. Compared with the native NADH, kinetics and molecular docking studies with 8-(6-aminohexyl)-amino-NADH showed that its binding with alcohol dehydrogenase (ADH) was not much affected or even enhanced by a factor of 4.9-fold with lactate dehydrogenase (LDH), but complicated the binding of substrates to the enzymes. For ADH, the Michaelis constant for acetaldehyde decreased from 0.47 to 0.048 mM, while that of sodium pyruvate with LDH increased to 0.81 from 0.18 mM. On the other hand, the modified coenzyme showed a 19.3-fold decrease in turnover number (k(cat)) with ADH, while a slight increase with LDH. Molecular docking analysis showed that the hexanediamine arm on the modified coenzyme generated an extra hydrogen bond at the active site of ADH, as well as additional hydrophobic interactions with both ADH and LDH. It appeared that the apparently decreased reactivity of modified cofactor with ADH was caused mainly by the enhanced stability of ternary coenzyme-enzyme-substrate complex, while in the case of LDH, the reduced substrate binding as a result of the chemical modification of NADH led to a slight increase in the overall reaction reactivity. (C) 2012 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.molcatb.2012.01.018
  • 作为产物:
    描述:
    β-烟酰胺腺嘌呤二核苷酸 在 acetate buffer 、 作用下, 以 为溶剂, 反应 1.0h, 生成 8-Br-NAD+
    参考文献:
    名称:
    氟化NAD作为可溶辅酶的合成,用于在含氟溶剂和二氧化碳中进行酶促化学反应
    摘要:
    报道了具有共价连接的氟化聚合物的辅酶烟酰胺腺嘌呤二核苷酸(NAD)的合成。由于全氟聚醚的附着,使得氟化NAD(FNAD)可溶于氟溶剂和液态二氧化碳中。马肝醇脱氢酶(HLADH)在含氟溶剂,甲氧基九氟丁烷(HFE)和液态二氧化碳中使用FNAD作为可溶性辅酶的催化氧化/还原反应中具有活性。在两种溶剂中,使用FNAD的HLADH的活性均大于相同摩尔量的未修饰(不溶)NAD,表明可溶性辅酶可导致更有效的反应。
    DOI:
    10.1016/s0040-4020(02)00259-4
点击查看最新优质反应信息

文献信息

  • Synthesis of conjugates of 11α-hydroxyprogesterone with β-nicotinamide adenine dinucleotide (β-NAD) and adenosine triphosphate (ATP)
    作者:David N. Kirk、Barry W. Miller
    DOI:10.1039/p19880002983
    日期:——
    Conjugates of 11α-hydroxyprogesterone with adenosine triphosphate and nicotinamide adenine dinucleotide have been prepared in which the steroid is attached to the nucleotides via bridges from C-11 to the terminal phosphate and C-8 positions of ATP, and to the N-6 and C-8 positions on the adenine ring of NAD. Preliminary evaluation of the bioluminescence of these conjugates is reported.
    已经制备了11α-羟基孕酮与三磷酸腺苷和烟酰胺腺嘌呤二核苷酸的结合物,其中类固醇通过从C-11到ATP的末端磷酸和C-8位置以及N-6和C的桥连接到核苷酸上。 NAD腺嘌呤环上的-8位。报道了对这些缀合物的生物发光的初步评估。
  • 2′-Deoxy Cyclic Adenosine 5′-Diphosphate Ribose Derivatives: Importance of the 2′-Hydroxyl Motif for the Antagonistic Activity of 8-Substituted cADPR Derivatives
    作者:Bo Zhang、Gerd K. Wagner、Karin Weber、Clive Garnham、Anthony J. Morgan、Antony Galione、Andreas H. Guse、Barry V. L. Potter
    DOI:10.1021/jm7010386
    日期:2008.3.1
    The structural features needed for antagonism at the cyclic ADP-ribose (cADPR) receptor are unclear. Chemoenzymatic syntheses of novel 8-substituted 2'-deoxy-cADPR analogues, including 8-bromo-2'-deoxy-cADPR 7, 8-amino-2'-deoxy-cADPR 8, 8-O-methyl-2'-deoxy-cADPR 9, 8-phenyl-2'-deoxy-cADPR 10 and its ribose counterpart 8-phenyl-cADPR 5 are reported, including improved syntheses of established antagonists 8-amino-cADPR 2 and 8-bromo-cADPR 3. Aplysia californica ADP-ribosyl cyclase tolerates even the bulky 8-phenyl-nicotinamide adenine 5'-dinucleotide as a substrate. Structure-activity relationships of 8-substituted cADPR analogues in both Jurkat T-lymphocytes and sea urchin egg homogenate (SUH) were investigated. 2'-OH Deletion decreased antagonistic activity (at least for the 8-amino series), showing it to be an important motif. Some 8-substituted 2'-deoxy analogues showed agonist activity at higher concentrations, among which 8-bromo-2'-deoxy-cADPR 7 was, unexpectedly, a weak but almost full agonist in SUH and was membrane-permeant in whole eggs. Classical antagonists 2 and 3 also showed. previously unobserved agonist activity at higher concentrations in both systems. The 2'-OH group, without effect on the Ca(2+)-mobilizing ability of cADPR itself, is an important motif for the antagonistic activities of 8-substituted cADPR analogues.
  • KIRK, DAVID N.;MILLER, BARRY W., J. CHEM. SOC. PERKIN TRANS. PT 1,(1988) N1, C. 2983-2992
    作者:KIRK, DAVID N.、MILLER, BARRY W.
    DOI:——
    日期:——
  • Synthesis of fluorinated NAD as a soluble coenzyme for enzymatic chemistry in fluorous solvents and carbon dioxide
    作者:Janice L Panza、Alan J Russell、Eric J Beckman
    DOI:10.1016/s0040-4020(02)00259-4
    日期:2002.5
    reported. The fluorinated NAD (FNAD) was rendered soluble in both fluorous solvents and liquid carbon dioxide due to the attachment of a perfluoropolyether. The enzyme horse liver alcohol dehydrogenase (HLADH) was active in catalyzing oxidation/reduction reactions using FNAD as a soluble coenzyme in a fluorous solvent, methoxynonafluorobutane (HFE), and liquid carbon dioxide. In both solvents, the activity
    报道了具有共价连接的氟化聚合物的辅酶烟酰胺腺嘌呤二核苷酸(NAD)的合成。由于全氟聚醚的附着,使得氟化NAD(FNAD)可溶于氟溶剂和液态二氧化碳中。马肝醇脱氢酶(HLADH)在含氟溶剂,甲氧基九氟丁烷(HFE)和液态二氧化碳中使用FNAD作为可溶性辅酶的催化氧化/还原反应中具有活性。在两种溶剂中,使用FNAD的HLADH的活性均大于相同摩尔量的未修饰(不溶)NAD,表明可溶性辅酶可导致更有效的反应。
  • Kinetics and docking studies on the effect of chemical modification of NADH for redox reactions with dehydrogenases
    作者:Hongjing Ma、Songping Zhang、Zhiguo Su、Ping Wang
    DOI:10.1016/j.molcatb.2012.01.018
    日期:2012.5
    Cofactor analogs promise important applications in biosynthesis. The effect of chemical modification on the reactivity of NADH for redox reactions catalyzed by dehydrogenases was examined in this work. Compared with the native NADH, kinetics and molecular docking studies with 8-(6-aminohexyl)-amino-NADH showed that its binding with alcohol dehydrogenase (ADH) was not much affected or even enhanced by a factor of 4.9-fold with lactate dehydrogenase (LDH), but complicated the binding of substrates to the enzymes. For ADH, the Michaelis constant for acetaldehyde decreased from 0.47 to 0.048 mM, while that of sodium pyruvate with LDH increased to 0.81 from 0.18 mM. On the other hand, the modified coenzyme showed a 19.3-fold decrease in turnover number (k(cat)) with ADH, while a slight increase with LDH. Molecular docking analysis showed that the hexanediamine arm on the modified coenzyme generated an extra hydrogen bond at the active site of ADH, as well as additional hydrophobic interactions with both ADH and LDH. It appeared that the apparently decreased reactivity of modified cofactor with ADH was caused mainly by the enhanced stability of ternary coenzyme-enzyme-substrate complex, while in the case of LDH, the reduced substrate binding as a result of the chemical modification of NADH led to a slight increase in the overall reaction reactivity. (C) 2012 Elsevier B.V. All rights reserved.
查看更多

同类化合物

鸟苷(5')四磷酰(5')鸟苷 还原辅酶Ⅱ四钠盐 还原型辅酶Ⅰ 还原型辅酶II(NADPH)四钠盐 苯(甲)醛,4-乙酰基-,1-肟 腺苷(5')四磷酸酯尿苷 硫代辅酶腺嘌呤二核苷磷酸钠 硫代烟酰胺-DPN 甲基N~5~-(二氨基甲亚基)-N~2~-[(3S,4S)-3-羟基-4-({N-[(4S)-3-羟基-6-甲基-4-{[(2S)-3-甲基-1-{[N-(3-甲基丁酰)-L-缬氨酰]氨基}-1-羰基丁烷-2-基]氨基}庚酰]-L-丙氨酰}氨基)-6-甲基庚酰]-L-鸟氨酸酸酯 烟酸腺嘌呤二核苷酸磷酸酯 烟酰胺腺嘌呤双核苷酸磷酸盐 烟酰胺腺嘌呤二核苷酸 烟酰胺1,N(6)-乙烯桥腺嘌呤二核苷酸 尿苷酰基-(3'-5')-腺苷酰-(3'-5')尿苷 尼克酰胺2-叠氮氨基嘌呤二核苷酸 地纽福索四钠 地夸磷索 八磷酸腺苷 二腺苷三磷酸酯铵盐 二喹唑醇杂质1 β-烟酰胺腺嘌呤二核苷酸 β,β'-单氯亚甲基二腺苷5',5''-P(1),P(4)-四磷酸酯 beta-烟酰胺腺嘌呤二核苷二钠 [[[[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [[[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰][(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰][(2R,3S,4R,5R)-5-(3,4-二甲基吡啶-1-鎓-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸酯 [[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰][(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基-8-叠氮基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[[(2R,3S,4R,5R)-5-(3-氨基甲酰-4H-吡啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]磷酸氢酯 P(1)-(腺苷-5')-P(5)-(胸苷-5')-五磷酸酯 BETA-烟酰胺腺嘌呤双核苷酸 Alpha-二磷酸啶核甙酸 3-苯甲酰基吡啶-腺嘌呤二核苷酸 3-氨基吡啶腺嘌呤二核苷酸 3-吡啶乙醛腺嘌呤二核苷酸 3-乙酰吡啶腺嘌呤二核苷酸 3'-脱氧烟酰胺腺嘌呤二核苷酸 2-氟-6-甲氧基苯甲腈 2'-脱氧腺苷酰-(3'-5')-胸苷 1-[5-[[[[5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲氧基-羟基-磷酰]氧基-羟基-磷酰]氧基甲基]-3,4-二羟基-四氢呋喃-2-基]吡啶-5-羧酸酯 1,6-二氢烟酰胺腺嘌呤二核苷酸 1,2-二氢烟酰胺腺嘌呤二核苷酸 (2S,3S,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基甲基]-2-(3-氨基甲酰吡啶-1-鎓-1-基)-4-羟基四氢呋喃-3-醇 (2R,3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基甲基]-2-(3-氨基甲酰-5-甲基吡啶-1-鎓-1-基)-4-羟基四氢呋喃-3-醇 (14β)-8-甲基罗汉松-12-烯-13,14-二甲醛 P1,P4-bis(uridin-5'-yl) tetraphosphate 2',2'',3',3''-O-tetrabutyryl 1,N6-etheno NAD+ β-nicotinamide adenine dinucleotide reduced 3'-azido-3'-deoxy-5'-thymidinyl 5'-uridinyl phosphate 5'-adenosyl 3'-azido-3'-deoxy-5'-thymidinyl phosphate